ENHANCED BIOACTIVITY OF MAMMALIAN SOMATOTROPIN THROUGH SELECTIVE DEAMIDATION

Deamidated forms of mammalian somatotropins originally having an asparagine located between residues 96-101. These deamidated somatotropins have an increased bioactivity as compared to their native species. This invention particularly discloses a composition comprised of bovine somatotropin (bSt) co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HOOGERHEIDE, JOHN, G, HARBOUR, GARY, C, GARLICK, ROBERT, L
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Deamidated forms of mammalian somatotropins originally having an asparagine located between residues 96-101. These deamidated somatotropins have an increased bioactivity as compared to their native species. This invention particularly discloses a composition comprised of bovine somatotropin (bSt) compounds wherein the bSt has been modified by deamidation from the native state comprising a predominant electrophoretic species having an isoelectric point (pI) of 8.2 to a bioenhanced composition of bSt molecules having a predominant electrophoretic species with pI between 7.5 and 6.5. The preferred bovine somatotropin is that species in which the asparagine located between amino acid residues 96-101 has been modified to isoaspartic acid. Processes for the production of these bioenhanced compositions and for their use are also disclosed.